Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METFORMIN\SITAGLIPTIN Cause Fall? 137 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 137 reports of Fall have been filed in association with METFORMIN\SITAGLIPTIN. This represents 1.6% of all adverse event reports for METFORMIN\SITAGLIPTIN.

137
Reports of Fall with METFORMIN\SITAGLIPTIN
1.6%
of all METFORMIN\SITAGLIPTIN reports
29
Deaths
78
Hospitalizations

How Dangerous Is Fall From METFORMIN\SITAGLIPTIN?

Of the 137 reports, 29 (21.2%) resulted in death, 78 (56.9%) required hospitalization, and 26 (19.0%) were considered life-threatening.

Is Fall Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METFORMIN\SITAGLIPTIN. However, 137 reports have been filed with the FAERS database.

What Other Side Effects Does METFORMIN\SITAGLIPTIN Cause?

Blood glucose increased (709) Acute kidney injury (616) Lactic acidosis (557) No adverse event (539) Diarrhoea (513) Inappropriate schedule of drug administration (469) Product dose omission issue (452) Pancreatic carcinoma (431) Drug ineffective (384) Nausea (378)

What Other Drugs Cause Fall?

ADALIMUMAB (11,399) CARBIDOPA\LEVODOPA (7,132) LENALIDOMIDE (6,229) ETANERCEPT (5,839) DALFAMPRIDINE (5,554) APIXABAN (5,063) METHOTREXATE (4,250) DIMETHYL (4,208) TOFACITINIB (4,064) PREGABALIN (4,047)

Which METFORMIN\SITAGLIPTIN Alternatives Have Lower Fall Risk?

METFORMIN\SITAGLIPTIN vs METFORMIN\VILDAGLIPTIN METFORMIN\SITAGLIPTIN vs METHADONE METFORMIN\SITAGLIPTIN vs METHAMPHETAMINE METFORMIN\SITAGLIPTIN vs METHENAMINE HIPPURATE METFORMIN\SITAGLIPTIN vs METHIMAZOLE

Related Pages

METFORMIN\SITAGLIPTIN Full Profile All Fall Reports All Drugs Causing Fall METFORMIN\SITAGLIPTIN Demographics